195 related articles for article (PubMed ID: 22553402)
1. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
Takino J; Yamagishi S; Takeuchi M
World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
[TBL] [Abstract][Full Text] [Related]
2. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.
Sakuraoka Y; Sawada T; Okada T; Shiraki T; Miura Y; Hiraishi K; Ohsawa T; Adachi M; Takino J; Takeuchi M; Kubota K
World J Gastroenterol; 2010 Nov; 16(42):5334-41. PubMed ID: 21072897
[TBL] [Abstract][Full Text] [Related]
3. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
Takino J; Kobayashi Y; Takeuchi M
J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization.
Puddu A; Sanguineti R; Durante A; Nicolò M; Viviani GL
Mol Vis; 2012; 18():2509-17. PubMed ID: 23112566
[TBL] [Abstract][Full Text] [Related]
5. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
6. In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.
Takino J; Nagamine K; Takeuchi M; Hori T
World J Gastroenterol; 2015 Feb; 21(6):1784-93. PubMed ID: 25684943
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
Hachiya H; Miura Y; Inoue K; Park KH; Takeuchi M; Kubota K
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):134-41. PubMed ID: 23798335
[TBL] [Abstract][Full Text] [Related]
9. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
[TBL] [Abstract][Full Text] [Related]
10. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
11. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products.
Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S
Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702
[TBL] [Abstract][Full Text] [Related]
12. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells.
Iwamoto K; Kanno K; Hyogo H; Yamagishi S; Takeuchi M; Tazuma S; Chayama K
J Gastroenterol; 2008; 43(4):298-304. PubMed ID: 18458846
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
Mao Z; Baker JR; Takeuchi M; Hyogo H; Tjønneland A; Eriksen AK; Severi G; Rothwell J; Laouali N; Katzke V; Kaaks R; Schulze MB; Palli D; Sieri S; de Magistris MS; Tumino R; Sacerdote C; Derksen JWG; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Guevara M; Harlid S; Johansson I; Perez-Cornago A; Freisling H; Gunter M; Weiderpass E; Heath AK; Aglago E; Jenab M; Fedirko V
Int J Cancer; 2023 Jun; 152(11):2257-2268. PubMed ID: 36715363
[TBL] [Abstract][Full Text] [Related]
18. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes.
Cheng CL; Tang Y; Zheng Z; Liu X; Ye ZC; Wang C; Lou TQ
Clin Invest Med; 2012 Oct; 35(5):E282. PubMed ID: 23043709
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]